ATH alterity therapeutics limited

PBT2, page-32

  1. 3,713 Posts.
    lightbulb Created with Sketch. 351
    No one knows the answer until the definitive results are released.

    Brain preservation as was seen in previous human and animal studies, likely due to the preservation of the what was affected brain cells.

    The 62% reduction in clinical response likely due to a quick removal of the excess iron, but with time it may have been too much and would probably start to see worsening which was seen in another study. The 50mg was much better with continual improveme t which would prove it effectively removed the excess iron and at a steady level to improve the prs condition.

    But than, you also have to consider which pts were which and how much iron and NfL readings each patient had with each dose, which we wont know for afew more weeks.

    I would assume this is also why Pivalde may have not provided his thoughts.

    Everything at this point is an assumption/prediction.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.001(6.67%)
Mkt cap ! $147.3M
Open High Low Value Volume
1.5¢ 1.7¢ 1.5¢ $770.2K 49.71M

Buyers (Bids)

No. Vol. Price($)
8 2038332 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 349000 2
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.